Accessibility Menu
EMVision Medical Devices logo

EMVision Medical Devices(ASX) EMV

Market CapA$164.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+479%
5 Year-43%
1 Year+1%
1 Month+13%
A$1.73
-1.98%
-0.03Today
EMVision Medical Devices last closing stock price
MetricPriceDate
Last closeAUD 1.732026-08-13
EMVision Medical Devices stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.79%AUD 1.622026-08-06
1 month+13.44%AUD 1.532026-07-14
3 month-0.86%AUD 1.752026-05-15
Year to date-2.81%AUD 1.782025-12-31
1 year+1.47%AUD 1.712025-08-13
3 year+24.01%AUD 1.402023-08-14
5 year-42.9%AUD 3.032021-08-13
Since inception+478.69%AUD 0.312018-12-13

EMVision Medical Devices Financials at a Glance

Market Cap

A$164.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$9.62M

Net Income (TTM)

-A$16.39M

EPS (TTM)

-A$0.12

P/E Ratio

-15.03

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$1.73

Volume

0

Open

A$1.76

Previous Close

A$1.73

Daily Range

A$1.70 - A$1.76

52-Week Range

A$1.47 - A$2.43

Estimated Earnings Date

Sep 2, 2026

EMV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EMVision Medical Devices

EMVision Medical Devices Ltd is an Australian company focused on the innovation and development of advanced imaging and diagnostic healthcare technologies. The company specializes in a compact, mobile brain scanner designed for rapid stroke detection and continuous monitoring, addressing critical medical imaging needs.

Products and Services
  • Compact mobile brain scanner for stroke detection
  • Advanced imaging technologies for various medical applications
  • Continuous tracking solutions for patient diagnostics
Growth Outlook
  • Significant market potential in stroke detection technology
  • Increasing demand for portable medical imaging solutions
  • Strategic partnerships to enhance product development and market reach
Financial Highlights
  • Recent quarterly revenue of AUD 6.65 million, showing growth potential
  • Cash reserves of AUD 17.55 million, providing operational stability
  • Current ratio of 12.94, indicating strong liquidity position
EMVision Medical Devices Ltd operates in the healthcare sector, specifically within the medical devices industry. The company has established itself as a pioneer in developing innovative solutions that cater to urgent medical needs, particularly in stroke management. The compact brain scanner not only enhances the speed of diagnosis but also improves patient outcomes through timely intervention. The growth outlook for EMVision is promising, driven by the increasing prevalence of stroke and the need for efficient diagnostic tools. The company is well-positioned to capitalize on the growing demand for portable imaging technologies, which are becoming essential in various healthcare settings. Strategic partnerships and collaborations are expected to further bolster product development and expand market access. Financially, EMVision has demonstrated resilience with a recent quarterly revenue of AUD 6.65 million, reflecting its ability to generate income despite the challenges faced in the medical device sector. The company maintains a robust cash position of AUD 17.55 million, ensuring it can support ongoing operations and future growth initiatives. With a current ratio of 12.94, EMVision showcases a strong liquidity position, which is crucial for navigating the dynamic healthcare landscape. Overall, EMVision Medical Devices Ltd presents a compelling opportunity for investors interested in innovative healthcare solutions, particularly in the realm of medical imaging and diagnostics.
AI Generated • Aug 2, 2026

Industry

Healthcare Equipment and Supplies

CEO

Scott Kirkland

Headquarters

Macquarie Park, NSW 2113, AU

EMV Financials

Key Financial Metrics (TTM)

Gross Margin

86.26%

Operating Margin

-825.16%

Net Income Margin

-652.61%

Return on Equity

-70.29%

Return on Capital

-63.42%

Return on Assets

-40.90%

Earnings Yield

-6.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$164.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

92.96M

Volume

0

Avg. Volume

40.37K

Financials (TTM)

Gross Profit

A$9.41M

Operating Income

-A$18.17M

EBITDA

-A$18.49M

Operating Cash Flow

-A$18.44M

Capital Expenditure

-A$180.25K

Free Cash Flow

-A$18.62M

Cash & ST Invst.

A$17.56M

Total Debt

A$4.02M

EMVision Medical Devices Performance Analysis

EMVision Medical Devices annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 0N/A
20232023-06-30AUD 0N/A
20242024-06-30AUD 0N/A
20252025-06-30AUD 0N/A
EMVision Medical Devices sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-31.2%
Q22024-12-31-23.7%
Q42025-06-30-55.2%
Q22025-12-31-100.0%
EMVision Medical Devices annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.08N/A
20232023-06-30AUD -0.05-38.7%
20242024-06-30AUD -0.03-31.9%
20252025-06-30AUD -0.11238.6%
EMVision Medical Devices sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-2157.1%
Q22024-12-31-32.3%
Q42025-06-30-74.6%
Q22025-12-3139.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$214.72K

-103.3%

Gross Margin

0.00%

N/A

Market Cap

A$164.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$3.57M

N/A

Employees

46

N/A

Net Income

-A$3.97M

-3423.5%

EBITDA

-A$7.69M

-101.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$17.56M

+107.1%

Total Debt

A$4.02M

+35.3%

Accounts Receivable

A$5.75M

+311.8%

Inventory

A$0.00

N/A

Long Term Debt

A$3.77M

+1872.9%

Short Term Debt

A$250.44K

-91.0%

Return on Assets

-40.90%

N/A

Return on Invested Capital

-55.76%

N/A

Free Cash Flow

-A$6.00M

-338.8%

Operating Cash Flow

-A$5.94M

-348.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NYR.AXNyrada Inc.
A$0.71-8.39%
ONE.AXOneview Healthcare PLC
A$0.16+0.00%
ALC.AXAlcidion Group Limited
A$0.09+1.11%
LDX.AXLumos Diagnostics Holdings Limited
A$0.12+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.56+0.02%
CDECoeur Mining
$18.45-0.02%
TAT&T
$24.58+0.01%
SMRNuScale Power
$9.85+0.03%

Questions About EMV

What is the current price of EMVision Medical Devices?

EMVision Medical Devices is trading at A$1.73 per share.

What is the 52-week range for EMVision Medical Devices?

Over the past 52 weeks, EMVision Medical Devices has traded between A$1.47 and A$2.43.

How much debt does EMVision Medical Devices have?

As of the most recent reporting period, EMVision Medical Devices reported total debt of A$3.53M.

How much cash does EMVision Medical Devices have on hand?

EMVision Medical Devices reported A$10.46M in cash and cash equivalents in its most recent financial results.

What is EMVision Medical Devices’s dividend yield?

EMVision Medical Devices does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.